Skip to main content

Table 1 Clinical characteristics and laboratory data of analyzed subjects classified by OGTT (N = 512)

From: Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients

  Overall (n = 512) NGT (n = 220, 42.9%) IGT (n = 191, 37.3%) DM (n = 101, 19.7%) p-value
Female (%) 60.5% 58.6% 58.6% 68.3% 0.205
Age (years) 50.3 ± 12.7 48.4 ± 12.8 50.3 ± 11.4 54.3 ± 14 0.001
BMI (kg/m2) 26.5 ± 4.6 26.1 ± 4.7 26.7 ± 4.5 27.0 ± 4.6 0.189
Systolic BP (mmHg) 126 ± 16 124 ± 16 126 ± 15 131 ± 15 < 0.001
Diastolic BP(mmHg) 74 ± 11 74 ± 11 75 ± 11 74 ± 11 0.578
Fasting plasma glucose 103 ± 12 98 ± 9 103 ± 11 112 ± 15 < 0.001
2-h plasma glucose 155 ± 51 111 ± 19 163 ± 17 236 ± 29 < 0.001
Hypertension 31.8% 27.7% 32.5% 39.6% 0.103
History of smoking 10.4% 11.0% 11.1% 7.9% 0.422
Statin usage 37% 34% 40% 40% 0.370
History of CVD 2.3% 1.8% 2.1% 4.0% 0.339
Family History of DM 60.2% 57.7% 59.7% 66.3% 0.339
HbA1c (%NGSP) 5.8 ± 0.5 5.6 ± 0.4 5.8 ± 0.5 6.1 ± 0.5 < 0.001
Total Cholesterol (mg/dL) 199 ± 39 199 ± 39 198 ± 40 200 ± 36 0.949
Fasting Triglyceride (mg/dL) 138 ± 83 128 ± 75 149 ± 102 138 ± 48 0.081
HDL (mg/dL) 53 ± 15 55 ± 16 51 ± 15 52 ± 12 0.048
LDL (mg/dL) 125 ± 37 125 ± 38 126 ± 39 124 ± 30 0.883
VFAa (cm2) 130 ± 39 129 ± 41 131 ± 39 129 ± 34 0.963
WC (cm) 94.5 ± 13 94.1 ± 13 94.9 ± 13 94.7 ± 12 0.909
Thai DM risk score (points) 9 ± 4 8 ± 4 9 ± 3 10 ± 3 0.003
Thai CV risk scoreb (points) 4 (1–10) 3 (1–7) 4 (1–9) 10 (2–19) < 0.001
  1. a Available in 268/512 overall subjects (107/220 in NGT, 112/191 in IGT, 49/101 in DM)
  2. b Displayed as median (IQR)